Anticancer Research Journal Issues Research Articles in October 2024 Edition
October 01, 2024
October 01, 2024
HIGHLANDS, New Jersey, Oct. 1 -- Anticancer Research, a peer-reviewed journal that says it features experimental and clinical oncology from the International Institute of Anticancer Research, published research articles on the following topics in its October 2024 edition (Vol. 44, Issue 10):
Reviews
* True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan
* Role of the Hippo-YAP/TAZ Pathway in Epithelioid H . . .
Reviews
* True Benefits of Immune Checkpoint Inhibitors in the Treatment of Malignant Pleural Mesothelioma in Japan
* Role of the Hippo-YAP/TAZ Pathway in Epithelioid H . . .